×
Cooper Revenue 2010-2024 | COO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cooper revenue for the twelve months ending October 31, 2024 was
$3.895B
, a
8.41% increase
year-over-year.
Cooper annual revenue for 2024 was
$3.895B
, a
8.41% increase
from 2023.
Cooper annual revenue for 2023 was
$3.593B
, a
8.61% increase
from 2022.
Cooper annual revenue for 2022 was
$3.308B
, a
13.2% increase
from 2021.
View More
Cooper Revenue 2010-2024 | COO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cooper annual revenue for 2024 was
$3.895B
, a
8.41% increase
from 2023.
Cooper annual revenue for 2023 was
$3.593B
, a
8.61% increase
from 2022.
Cooper annual revenue for 2022 was
$3.308B
, a
13.2% increase
from 2021.
Related Stocks
Company Name
Market
Cap
McKesson (MCK)
$76.6B
Becton Dickinson (BDX)
$71.6B
Cardinal Health (CAH)
$30.9B
West Pharmaceutical Services (WST)
$24.6B
Straumann Holding AG (SAUHY)
$23.1B
Labcorp (LH)
$20.6B
Align Technology (ALGN)
$16.8B
Henry Schein (HSIC)
$10B
Merit Medical Systems (MMSI)
$6.3B
DENTSPLY SIRONA (XRAY)
$3.9B
Patterson (PDCO)
$2.7B
CONMED (CNMD)
$2.2B
STAAR Surgical (STAA)
$1.2B
Lifevantage (LFVN)
$274M
Pro-Dex (PDEX)
$141M